![]() |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CARDIOVASCULAR
Department of Pharmacology, Georgetown University Medical Center, Washington, DC (T.T., Q.R., M.O., A.N.K., J.C.P., S.N.E.); Laboratory of Mammalian Genes and Development, National Institute of Child Health and Human Development/National Institutes of Health, Bethesda, Maryland (M.C.C., K.P.); Drug and Chemical Evaluation Section, Office of Diversion Control, Drug Enforcement Administration, Washington DC (S.T.)
We have previously shown that targeted disruption of the mouse Kcnq1 gene produces a long QT phenotype in vivo that requires extracardiac factors for manifestation (Casimiro et al., 2001). In the present study, we explore the hypothesis that autonomic neuroeffector transmission represents the "extra cardiac" stimulus that induces a long QT phenotype in mouse hearts lacking Kcnq1. Using the isolated perfused (Langendorff) mouse heart preparation, we challenged wild-type (Kcnq1+/+) and mutant (Kcnq1-/-) mouse hearts with nicotine, an autonomic stimulant. ECGs were recorded continuously, and QT intervals were compared at baseline and peak nicotine-induced heart rates. No significant differences in QT or any other ECG parameters were observed in Kcnq1+/+ versus Kcnq1-/- hearts at baseline. In the presence of nicotine, however, the JT, QT, and rate-corrected QT (QTc) intervals were significantly prolonged in Kcnq1-/- hearts relative to Kcnq1+/+ hearts (e.g., QTc = 92 ± 11 ms versus 66 ± 2 ms, respectively, p < 0.01). Similar findings were obtained when the hearts were challenged with either epinephrine or isoproterenol (0.1 µM each), thereby suggesting that sympathetic stimulation drives the long QT phenotype in Kcnq1-deficient hearts. This idea is supported by in vivo ECG data obtained from unrestrained conscious mice using radiotelemetry recording techniques. Again, no significant ECG differences were observed in Kcnq1-/- versus Kcnq1+/+ mice at baseline, but handling/injection stress led to significant QTc increases in Kcnq1-/- mice relative to wild-type controls (11 ± 3 versus -1 ± 1%, respectively, p < 0.05). These data suggest that sympathetic stimulation induces a long QT phenotype in Kcnq1-deficient mouse hearts.
Address correspondence to: Dr. Steven N. Ebert, Department of Pharmacology, Georgetown University Medical Center, 3900 Reservoir Rd., NW, Washington, DC 20057. E-mail: eberts{at}georgetown.edu
This article has been cited by other articles:
![]() |
F. Suto, W. Zhu, A. Chan, and G. J. Gross IKr and IKs remodeling differentially affects QT interval prolongation and dynamic adaptation to heart rate acceleration in bradycardic rabbits Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1782 - H1788. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Thomas, M. J. Killeen, I. S. Gurung, P. Hakim, R. Balasubramaniam, C. A. Goddard, A. A. Grace, and C. L.-H. Huang Mechanisms of ventricular arrhythmogenesis in mice following targeted disruption of KCNE1 modelling long QT syndrome 5 J. Physiol., January 1, 2007; 578(1): 99 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gohma, T. Kuramoto, M. Kuwamura, R. Okajima, N. Tanimoto, K.-i. Yamasaki, S. Nakanishi, K. Kitada, T. Makiyama, M. Akao, et al. WTC deafness Kyoto (dfk): a rat model for extensive investigations of Kcnq1 functions Physiol Genomics, February 23, 2006; 24(3): 198 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Knollmann, M. C. Casimiro, A. N. Katchman, S. G. Sirenko, T. Schober, Q. Rong, K. Pfeifer, and S. N. Ebert Isoproterenol Exacerbates a Long QT Phenotype in Kcnq1-Deficient Neonatal Mice: Possible Roles for Human-Like Kcnq1 Isoform 1 and Slow Delayed Rectifier K+ Current J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 311 - 318. [Abstract] [Full Text] [PDF] |
||||